Αρχική World News FDA Approves Oral Combination of Decitabine and Cedazuridine Tablets with Venetoclax for... World News FDA Approves Oral Combination of Decitabine and Cedazuridine Tablets with Venetoclax for Newly Diagnosed AML Από Ogkologos - 3 Ιουνίου, 2026 273 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the Study ASTX727-07 Source ΠΑΡΟΜΟΙΑ ΑΡΘΡΑΠΕΡΙΣΣΟΤΕΡΑ ΑΠΟ ΤΟΝ ΔΗΜΙΟΥΡΓΟ Ahead of the Special European Council Meeting on 26-27 November, ESMO Calls on EU Governments to Continue Support for the Cancer Mission European Parliament backs key priorities advocated by ESMO for cancer research and innovation FDA approves giredestrant in combination with everolimus for ER-positive, HER2-negative, ESR1-mutated locally advanced or metastatic breast cancer MOST POPULAR Get the Most out of Seasonal Fruits! 28 Δεκεμβρίου, 2020 FDA Sends Out Warning To Dollar Tree For Selling “Potentially Unsafe... 20 Νοεμβρίου, 2019 Why we need to continue to advocate for global tobacco control 30 Σεπτεμβρίου, 2022 Self-care Isn’t Selfish 25 Αυγούστου, 2021 Φόρτωση περισσοτέρων HOT NEWS Updated ROAR Analysis Confirms the Benefit of Dabrafenib Plus Trametinib in... Spending Review 2020 – Steps in the right direction, but opportunities... Here’s Why We’re Building Pet-Friendly Domestic Violence Shelters–And How You Can... ESMO Sarcoma and Rare Cancers Congress 2025, Lugano, Switzerland, 20-22 March